JOHN MACKEY: Open Payments
NPI 1275609984 · PLAINFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,559 in 203 payments from 25 companies in 2025. Trend: 2023 $3,463 · 2024 $3,753 · 2025 $3,559
Food & beverage: $3,536Education: $24
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $527 |
| GlaxoSmithKline, LLC. | 27 | $486 |
| ABBVIE INC. | 34 | $438 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $251 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $251 |
| Vanda Pharmaceuticals Inc. | 8 | $187 |
| Phathom Pharmaceuticals, Inc. | 12 | $178 |
| Axsome Therapeutics, Inc. | 7 | $157 |
| Novo Nordisk Inc | 10 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $148 |
Products named: JARDIANCE, VRAYLAR, Kerendia, NUCALA, FARXIGA, FANAPT, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across CT — which companies pay providers there.
